CAFFEINE AS A MODULATOR OF MITOPHAGY IN SACCHAROMYCES CEREVISIAE MODELS FOR PARKINSON’S DISEASE

Vol 3, 2025 - 330959
Abstract
Favorite this paper
How to cite this paper?
Abstract

Mitochondrial impairment and defective mitophagy are key features of Parkinson’s disease (PD), particularly in models involving mutations in PINK1 and Parkin, where mitochondrial clearance is compromised. These alterations increase oxidative stress and impair energy homeostasis, ultimately contributing to neuronal degeneration. Saccharomyces cerevisiae has proven to be a valuable model for dissecting mitochondrial dynamics and autophagic pathways due to its evolutionary conservation of core mechanisms and genetic accessibility. Epidemiological data consistently link caffeine consumption with reduced PD risk, suggesting that this compound may act as a modulator of neuronal resilience. While the neuroprotective association is well described, the cellular and molecular mechanisms remain unclear. In particular, whether caffeine directly affects mitochondrial quality control processes such as mitophagy has not been fully explored. In this study, wild-type (WTOM) and mitophagy-deficient (ΔATG32) yeast strains were cultured under standard conditions and treated with caffeine at 0 µM, 100 µM, 500 µM, 1000 µM, and 2000 µM. Cultures were normalized to OD600 0.2 before treatment. Preliminary analyses using fluorescence microscopy of mitochondria-targeted reporters revealed that caffeine modulates mitochondrial turnover in a concentration-dependent manner. Notably, WT cells exhibited increased mitochondrial fragmentation and vacuolar colocalization at intermediate concentrations (500–1000 µM), whereas ΔATG32 cells did not show this response, reinforcing the role of Atg32-dependent mitophagy. Higher concentrations (2000 µM) suggested a possible cytotoxic threshold, reflected in altered cell density and reduced signal consistency. Together, these findings suggest that caffeine interacts with mitophagy pathways in yeast, potentially enhancing mitochondrial clearance under stress conditions. By bridging epidemiological observations and mechanistic insights, our results highlight caffeine as a candidate modulator of mitochondrial quality control. These outcomes not only strengthen the role of S. cerevisiae as a simplified platform for studying PD-related processes but also support future investigations into dietary compounds as potential therapeutic adjuvants in neurodegenerative diseases.

This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and the Federal University of Santa Maria.

 

 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Federal University of Santa Maria
  • 2 Universidade Federal de Santa Maria | (Federal University of Santa Maria)
Track
  • 15. Bioenergetics
Keywords
Mitophagy
Mitochondries
Parkinson
Yeast
Caffeine